Shortage of Contrast for Imaging Services

Because of a global shortage of iodinated contrast material (Omnipaque) caused by temporary overseas manufacturing disruptions, ChristianaCare is taking steps to preserve supply so that it remains available for the most time-sensitive and urgent patient needs. (Learn more in our frequently asked questions.)

Omnipaque contrast is the most widely used contrast material for CT scans and radiographic examinations at ChristianaCare facilities. It is also used for cardiac imaging and interventions, and in the GI lab, Surgicenter and other settings.

The shortage is expected to last several weeks, and likely into the summer months.

Hospitals and health care organizations worldwide are managing the effects of the shortage and the impact to patient care.

ChristianaCare is making every effort to meet the needs of patients who need this product in their procedures. We are working individually with physicians to prioritize those patients with the most urgent needs.

Wherever possible, we are using alternative contrast material and limiting its use to ensure adequate supplies for time sensitive and emergent exams. It is possible that some elective procedures that use this product will need to be delayed.

ChristianaCare will continue to look for options to minimize disruptions created by the shortage, as we serve our community as expert, caring partners in health.

Learn more in our frequently asked questions (FAQs).

COVID-19: New Visitation Guidelines. Click here for what to expect at ChristianaCare during COVID-19.

ChristianaCare

Shortage of Contrast for Imaging Services

Because of a global shortage of iodinated contrast material (Omnipaque) caused by temporary overseas manufacturing disruptions, ChristianaCare is taking steps to preserve supply so that it remains available for the most time-sensitive and urgent patient needs. (Learn more in our frequently asked questions.)

Omnipaque contrast is the most widely used contrast material for CT scans and radiographic examinations at ChristianaCare facilities. It is also used for cardiac imaging and interventions, and in the GI lab, Surgicenter and other settings.

The shortage is expected to last several weeks, and likely into the summer months.

Hospitals and health care organizations worldwide are managing the effects of the shortage and the impact to patient care.

ChristianaCare is making every effort to meet the needs of patients who need this product in their procedures. We are working individually with physicians to prioritize those patients with the most urgent needs.

Wherever possible, we are using alternative contrast material and limiting its use to ensure adequate supplies for time sensitive and emergent exams. It is possible that some elective procedures that use this product will need to be delayed.

ChristianaCare will continue to look for options to minimize disruptions created by the shortage, as we serve our community as expert, caring partners in health.

Learn more in our frequently asked questions (FAQs).

COVID-19: New Visitation Guidelines. Click here for what to expect at ChristianaCare during COVID-19.

Helen F. Graham Cancer Center
& Research Institute

Survivorship

The end of your cancer treatment is cause for celebration. It also marks the beginning of your new life as a cancer survivor. Cancer and its treatment can impact every aspect of your life: physical, emotional, social and spiritual. Now you’ll need to find a new path forward as you adjust to your “new normal.”

What Will Life Look Like After Cancer?

For many, life after cancer is never quite the same — and this can be a good thing.

There is no single, correct way to be a survivor. Surviving cancer does not mean you are now expected to be happy every minute. Like everything else, being a cancer survivor has its challenges, and — just as you did during your treatment — you will learn how to get through them. We can help you do that.

Support for Survivors

Just as the Helen F. Graham Cancer Center & Research Institute has been with you throughout treatment, we are here for you in this new phase, whether you’ve just completed treatment or you’ve been a cancer survivor for years.

Established in 2006, our survivorship program was one of the first in the country and continually innovates to serve cancer survivors. Please consult the pages below for more information, or contact our Survivorship Nurse Navigator at 302-623-4866 to get the support you need.

Self Care for the Body, Mind and Spirit

Follow-up Care With Your Cancer Care Team

Side Effects After Cancer Treatment

Survivorship Program Calendar

Resources

Helen F. Graham Cancer Center & Research Institute
4701 Ogletown-Stanton Road, Newark, DE 19713 directions
302-623-4500